JP2023513156A5 - - Google Patents
Info
- Publication number
- JP2023513156A5 JP2023513156A5 JP2022547671A JP2022547671A JP2023513156A5 JP 2023513156 A5 JP2023513156 A5 JP 2023513156A5 JP 2022547671 A JP2022547671 A JP 2022547671A JP 2022547671 A JP2022547671 A JP 2022547671A JP 2023513156 A5 JP2023513156 A5 JP 2023513156A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- car
- hapten
- pharmaceutical composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969917P | 2020-02-04 | 2020-02-04 | |
| US62/969,917 | 2020-02-04 | ||
| PCT/US2021/016194 WO2021158534A1 (en) | 2020-02-04 | 2021-02-02 | Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513156A JP2023513156A (ja) | 2023-03-30 |
| JP2023513156A5 true JP2023513156A5 (cg-RX-API-DMAC10.html) | 2024-02-09 |
| JP7744914B2 JP7744914B2 (ja) | 2025-09-26 |
Family
ID=77200468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547671A Active JP7744914B2 (ja) | 2020-02-04 | 2021-02-02 | ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230172981A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4100026A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7744914B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20220164474A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115397440A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021216554A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3169804A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL295074A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021158534A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| CA3019835A1 (en) | 2016-04-08 | 2017-10-12 | Purdue Research Foundation | Methods and compositions for car t cell therapy |
| CN110582288B (zh) | 2017-02-28 | 2024-09-20 | 恩多塞特公司 | 用于car t细胞疗法的组合物和方法 |
| WO2019144095A1 (en) | 2018-01-22 | 2019-07-25 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Methods of use for car t cells |
| AU2019218729B2 (en) * | 2018-02-06 | 2025-12-04 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Fluorescein-specific CARs exhibiting optimal T cell function against FL-PLE labelled tumors |
| JP7568224B2 (ja) | 2018-02-23 | 2024-10-16 | エンドサイト・インコーポレイテッド | Car t細胞療法のための配列決定法 |
| IL295063A (en) | 2020-02-04 | 2022-09-01 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Chimeric antigen receptors (car) against dinitrophenol |
| US20250195651A1 (en) * | 2022-03-15 | 2025-06-19 | Celledit Llc | Use of antigen presenting cells to enhance car-t cell therapy |
| WO2024206913A2 (en) * | 2023-03-31 | 2024-10-03 | Northwestern University | Compositions for antigen-specific immune cell activation |
| EP4724087A1 (en) * | 2023-06-06 | 2026-04-15 | Danmarks Tekniske Universitet | A synthetic cellular advanced signal adapter (scasa) system |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020004052A1 (en) * | 1990-05-08 | 2002-01-10 | David Berd | Composition comprising a tumor cell extract and method of using the composition |
| HRP20240357T1 (hr) * | 2014-12-24 | 2024-06-07 | Autolus Limited | Stanica |
| KR20180095511A (ko) * | 2015-10-30 | 2018-08-27 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 표적화된 암 요법 |
| AU2017295704B2 (en) | 2016-07-13 | 2023-07-13 | President And Fellows Of Harvard College | Antigen-presenting cell-mimetic scaffolds and methods for making and using the same |
| US10617720B2 (en) * | 2016-10-20 | 2020-04-14 | Miltenyi Biotech, GmbH | Chimeric antigen receptor specific for tumor cells |
| EP3336107A1 (en) * | 2016-12-15 | 2018-06-20 | Miltenyi Biotec GmbH | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor |
| JP7078937B2 (ja) * | 2016-12-21 | 2022-06-01 | ダンマークス テクニスク ユニバーシテット | 免疫細胞を操作するための抗原提示足場 |
| AU2018219226B2 (en) * | 2017-02-07 | 2024-12-19 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents |
| CA3076337A1 (en) | 2017-09-19 | 2019-03-28 | Massachusetts Institute Of Technology | Compositions for chimeric antigen receptor t cell therapy and uses thereof |
| BR112020005938A2 (pt) * | 2017-09-27 | 2020-11-17 | University Of Southern California | célula imune ou população de células imunes da mesma, célula efetora imune ou célula-tronco, célula que apresenta antígeno, polinucleotídeo recombinante, vetor, composição que compreende uma célula imune efetora ou uma célula-tronco, métodos para produzir uma célula efetora imune que expressa receptor imune de ocorrência não natural, para gerar uma população de células manipuladas por rna, para fornecer imunidade antidoença em um indivíduo, para tratar ou prevenir uma doença associada à expressão de um antígeno, e, uso |
| AU2019218729B2 (en) | 2018-02-06 | 2025-12-04 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Fluorescein-specific CARs exhibiting optimal T cell function against FL-PLE labelled tumors |
| KR20210074274A (ko) * | 2018-08-06 | 2021-06-21 | 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 | 합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물 |
-
2021
- 2021-02-02 WO PCT/US2021/016194 patent/WO2021158534A1/en not_active Ceased
- 2021-02-02 EP EP21751276.3A patent/EP4100026A4/en active Pending
- 2021-02-02 IL IL295074A patent/IL295074A/en unknown
- 2021-02-02 KR KR1020227030136A patent/KR20220164474A/ko active Pending
- 2021-02-02 JP JP2022547671A patent/JP7744914B2/ja active Active
- 2021-02-02 AU AU2021216554A patent/AU2021216554A1/en active Pending
- 2021-02-02 US US17/758,960 patent/US20230172981A1/en active Pending
- 2021-02-02 CA CA3169804A patent/CA3169804A1/en active Pending
- 2021-02-02 CN CN202180019063.XA patent/CN115397440A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Song et al. | In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB) | |
| Yeku et al. | Adoptive T-cell therapy for solid tumors | |
| Liu et al. | Targeting alpha-fetoprotein (AFP)–MHC complex with CAR T-cell therapy for liver cancer | |
| JP5414750B2 (ja) | 治療および診断用抗Hsp70抗体 | |
| JP2021513961A5 (cg-RX-API-DMAC10.html) | ||
| US20230302155A1 (en) | Compositions and methods for in vivo generation of car expressing cells | |
| CN108603200B (zh) | 优化的慢病毒转移载体及其用途 | |
| KR20210134339A (ko) | 바이러스 전달을 위한 메조다공성 실리카 입자 조성물 | |
| JP2021502104A5 (cg-RX-API-DMAC10.html) | ||
| Rodriguez-Garcia et al. | T-cell target antigens across major gynecologic cancers | |
| CN108290955A (zh) | 人源化抗-cll-1抗体 | |
| CN115397440A (zh) | 用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物 | |
| JP2021505637A5 (cg-RX-API-DMAC10.html) | ||
| JP7541390B2 (ja) | 免疫チェックポイント分子と結合可能な分子が融合したタンパク質およびその用途 | |
| Vanhooren et al. | TARP as antigen in cancer immunotherapy | |
| Xia et al. | Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy | |
| Mashayekhi et al. | Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers | |
| JP2025515324A5 (cg-RX-API-DMAC10.html) | ||
| KR102562878B1 (ko) | 질환 항원이 융합된 단백질 및 이의 용도 | |
| CN118786142A (zh) | 用于治疗肿瘤的ror1 car或ror1/cd19双car t细胞 | |
| CN114853897A (zh) | 抗cd19/cd22/cd3三特异性抗体及用途 | |
| CN114763387A (zh) | 一种基于结构优化蛋白活性的三特异性抗体制备方法 | |
| WO2024148216A2 (en) | Combination therapy with t cell engager | |
| JP2025511909A (ja) | Itgb2媒介薬物伝達システム | |
| JP2025512377A5 (cg-RX-API-DMAC10.html) |